Earnings Call · Q4 FY2023·2024-02-21

Q4 23EPS +92.77%·Rev n/aQ3 23EPS +4.49%·Rev n/aQ2 23EPS +41.43%·Rev n/aQ1 23EPS +10.53%·Rev n/a⚠ consensus missing

IONIS PHARMACEUTICALS INC IONS

Wade Walke — Senior Vice President of Investor Relations

Brett Monia — Chief Executive Officer

Richard Geary — Executive (likely Chief Medical Officer or similar)

Beth Hougen — Executive (likely Chief Financial Officer or similar)

−1.8%1d on move date−1.9% vs SPY3d+2.3%5d+6.9%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more IONS calls or request research access.

More IONS calls Browse calls Request research access